Antigen processing and presentation articles within Gene Therapy

Featured

• Original Article | 17 April 2017

  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo

  • M L Palma
  • , P Duangkhae
  •  & E T A Marques

• Short Communication | 23 August 2015

  Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response

  • L Samaranch
  • , P Hadaczek
  •  & K S Bankiewicz

• Original Article | 08 January 2015

  Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro

  • T D Norton
  • , E A Miller
  •  & N R Landau

• Short Communication | 20 November 2014

  AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy

  • R Thwaite
  • , G Pagès
  •  & A Bosch

• Original Article | 09 August 2012

  TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells

  • M Haruta
  • , Y Tomita
  •  & S Senju

• Original Article
  12 January 2012 | Open Access

  Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells

  • C Goyvaerts
  • , K De Groeve
  •  & K Breckpot

• Original Article | 25 November 2010

  RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency

  • S-T Wang
  • , C-C Chang
  •  & C-C Lin

• Original Article | 05 August 2010

  Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics

  • G Ungerechts
  • , M E Frenzke
  •  & R Cattaneo